Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Nausea 1Gastrointestinal Neoplasms 1

Interventions

Dexamethasone 5Calcium Dobesilate 5fosaprepitant 3Ondansetron 3Aprepitant 3dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Olanzapine 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Haloperidol 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Nausea × dolasetron × Clear all
NCT02550119 2017-03-28

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

University of Southern California

Phase NA Terminated
19 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡